Kristina Drizyte‐Miller

UNC Lineberger Comprehensive Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer”.

Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer

Nature(2024)10.1038/s41586-024-07379-z

N/A

3.9DataRank · unranked

182 citations

Jingjing Jiang, Tanner C. Dalton, Álvaro Curiel‐García, A. Cole Edwards, Yingyun Wang +61 more

The anti-viral dynamin family member MxB participates in mitochondrial integrity

Nature Communications(2020)10.1038/s41467-020-14727-w

N/A

0.489DataRank · unranked

25 citations

Eugene W. Krueger, Jing Chen, Kristina Drizyte‐Miller, Mary E. Schulz, Mark A. McNiven +1 more

Characterization of TR ‐107, a novel chemical activator of the human mitochondrial protease ClpP

Pharmacology Research & Perspectives(2022)10.1002/prp2.993

N/A

0DataRank · unranked

43 citations

Lucas J. Aponte‐Collazo, Joshua D. Wynn, Kristina Drizyte‐Miller, Elisa Leung, Yoshimi Endo Greer +12 more

Characterization of TR-107, a Novel Chemical Activator of the Human Mitochondrial Protease ClpP

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.14.480426

N/A

0DataRank · unranked

1 citations

Lucas J. Aponte‐Collazo, Joshua D. Wynn, Kristina Drizyte‐Miller, Elisa Leung, Yoshimi Endo Greer +12 more

Tumor-selective effects of active RAS inhibition in pancreatic ductal adenocarcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.03.569791

N/A

0DataRank · unranked

11 citations

Jingjing Jiang, Alvaro Curiel-Garcia, Yingyun Wang, Bianca J. Lee, Margo Orlen +42 more

Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer.

UNC Libraries(2024)10.17615/s0p7-tg86

N/A

0DataRank · unranked

12 citations

Jennifer E. Klomp, Bjoern Papke, Craig M. Goodwin, Andrew P. Beelen, Clint A. Stalnecker +19 more

The small GTPase Rab32 resides on lysosomes to regulate mTORC1 signaling

Journal of Cell Science(2020)10.1242/jcs.236661

N/A

0DataRank · unranked

41 citations

Jing Chen, Hong Cao, Micah B. Schott, Mark A. McNiven, Kristina Drizyte‐Miller

Rab32 regulates Golgi structure and cell migration through Protein Kinase A–mediated phosphorylation of Optineurin

Proceedings of the National Academy of Sciences(2025)10.1073/pnas.2502971122

N/A

0DataRank · unranked

5 citations

Maxwell G. Marley, Kristina Drizyte‐Miller, Jing Chen, Hong Cao, Nourhan Mostafa +4 more

Combination Therapies with CDK4/6 Inhibitors to Treat KRAS- Mutant Pancreatic Cancer

Cancer Research(2022)10.1158/0008-5472.can-22-0391

N/A

0DataRank · unranked

163 citations

Andrew M. Waters, Jennifer E. Klomp, Sehrish Javaid, Kirsten L. Bryant, Clint A. Stalnecker +19 more